Status:
COMPLETED
Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Multiple Sclerosis Society
The University of Queensland
Conditions:
Multiple Sclerosis
Fatigue
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the effectiveness of two self-guided psychological treatments, Self-Hypnosis (HYP) and Mindfulness Meditation (MM) compared to Treatment as Usual (TAU) for peopl...
Detailed Description
People with multiple sclerosis (MS) often have problems with fatigue that can interfere with other treatments. As many as 90% of individuals with MS experience persistent fatigue and 40% of individual...
Eligibility Criteria
Inclusion
- Self-reported diagnosis of MS.
- Age 18 years old or older at the time of study enrollment.
- Presenting with clinically meaningful fatigue (i.e., reporting daily fatigue ≥50% of the days in the past 6 months with an average severity in the past week of ≥ 20 on the PROMIS Fatigue short form \[T-score, 56.4\]).
- Able to read, speak, and understand English.
- Access to an internet-enabled device (desktop/laptop/tablet/smart phone) to allow access to the recordings and to complete the study measures via the internet.
Exclusion
- Psychiatric condition or symptoms that would interfere with participation, specifically (a) current active suicidal ideation with current intent to harm oneself, (b) current psychosis, or (c) current mania.
- Currently receiving psychological treatment for fatigue more than once per month.
- Has received mindfulness meditation or hypnosis training in the past and has practiced mindfulness meditation/hypnosis in the past three months.
Key Trial Info
Start Date :
April 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT04688710
Start Date
April 30 2021
End Date
December 31 2023
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UW Medicine Multiple Sclerosis Center
Seattle, Washington, United States, 98133